Election 2020: The Next Phase of the US Healthcare Policy War
The results of this study are reflective of news as of October 19, 2020. An overview of key policies and additional details on overall feasibility by election outcome have been summarized in these supplemental materials.
From the senior members of the U.S. L.E.K. Consulting Healthcare Services and Life Sciences teams:
Wiley Bell, Managing Director
Kevin Grabenstatter, Managing Director
Jonathan Kfoury, Managing Director
Aru Murthy, Engagement Manager
Rosie Jiang, Global Healthcare Specialist
Max Reik, Senior Associate Consultant
Sam Rude, Senior Associate Consultant
Please reach out to us if you would like to continue the discussion.